Stocks and Investing Stocks and Investing
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022

Gena Wang Maintained (ZYME) at Hold with Increased Target to $9 on, Dec 22nd, 2022


Published on 2024-10-28 00:41:58 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Zymeworks Inc." (ZYME) at Hold with Increased Target from $7 to $9 on, Dec 22nd, 2022.

Gena has made no other calls on ZYME in the last 4 months.



There are 6 other peers that have a rating on ZYME. Out of the 6 peers that are also analyzing ZYME, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $10 on, Monday, November 21st, 2022
  • Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, October 21st, 2022


These are the ratings of the 4 analyists that currently disagree with Gena


  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $18 on, Monday, October 24th, 2022
  • Nick Abbott of "Wells Fargo" Initiated at Buy with Decreased Target to $9 on, Tuesday, October 4th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $21 on, Wednesday, September 14th, 2022
Contributing Sources